Abu Dhabi’s Mubadala, G42 launch tech-enabled healthcare firm

Abu Dhabi’s Mubadala, G42 launch tech-enabled healthcare firm

Abu Dhabi’s Mubadala Investment Company (Mubadala) and G42 Group have merged their healthcare assets to create M42, a tech-enabled healthcare company. The merged entity combines G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class patient services and healthcare facilities to provide the highest level of personalised, precise and preventative care, the Abu Dhabi-based entities said in a joint statement. M42 is expected to transform the way care is delivered while bridging the gap between the latest healthtech advancements and the clinical outcomes patients receive. The company will look at “opportunities for global expansion and partnerships with pharmaceutical, healthcare, and healthtech leaders to bring high-quality care to communities around the world.” It will be led by group CEO and managing director, Hasan Jasem Al Nowais. “Our vision is to transform lives through innovation by providing personalised and precise patient care. We are confident that through our operating companies, M42 will create a future in which dedicated healthcare professionals are empowered by the latest technology to optimize patient outcomes,” said Al Nowais. M42 will own a large portfolio, which includes Imperial College London Diabetes Centre, Danat Al Emarat, HealthPoint Hospital, Omics Center of Excellence and The National Reference Laboratory among